rts logo

Zomedica Corp (ZOM) down -30.07% since start of the year

Zomedica Corp (AMEX: ZOM) is -30.07% lower on its value in year-to-date trading and has touched a low of $0.12 and a high of $0.25 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ZOM stock was last observed hovering at around $0.14 in the last trading session, with the day’s loss setting it 0.0%.

Currently trading at $0.14, the stock is 2.56% and 4.81% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 7.16 million and changing 0.00% at the moment leaves the stock -18.57% off its SMA200. ZOM registered -34.64% loss for a year compared to 6-month loss of -16.22%. The firm has a 50-day simple moving average (SMA 50) of $2.06 and a 200-day simple moving average (SMA200) of -$4.14.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


The stock witnessed a -9.68% gain in the last 1 month and extending the period to 3 months gives it a -30.07%, and is 4.79% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.88% over the week and 5.87% over the month.

Zomedica Corp (ZOM) has around 144 employees, a market worth around $137.19M and $25.19M in sales. Profit margin for the company is -137.10%. Distance from 52-week low is 16.67% and -42.86% from its 52-week high. The company has generated returns on investments over the last 12 months (-14.28%).

Zomedica Corp quarterly earnings per share for the current quarter are estimated at $0 with sales reaching $8.18M over the same period., but quarterly earnings will post 35.40% year-over-year. Quarterly sales are estimated to grow 49.20% in year-over-year returns.

Zomedica Corp (ZOM) Top Institutional Holders

95 institutions hold shares in Zomedica Corp (ZOM), with institutional investors hold 9.32% of the company’s shares. The shares outstanding are 979.95M, and float is at 964.36M with Short Float at 6.00%. Institutions hold 9.17% of the Float.

The top institutional shareholder in the company is Vanguard Group Inc with over 48.81 million shares valued at $9.76 million. The investor’s holdings represent 4.98% of the ZOM Shares outstanding. As of Jun 29, 2023, the second largest holder is Blackrock Inc. with 11.51 million shares valued at $2.3 million to account for 1.17% of the shares outstanding. The other top investors are Cambridge Investment Research Advisors Inc. which holds 11.26 million shares representing 1.15% and valued at over $2.25 million, while Geode Capital Management, LLC holds 0.95% of the shares totaling 9.33 million with a market value of $1.87 million.

Zomedica Corp (ZOM) Insider Activity

The most recent transaction is an insider purchase by POWERS JOHNNY D,the company’sDirector. SEC filings show that POWERS JOHNNY D bought 100,000 shares of the company’s common stock on Dec 15 ’23 at a price of $0.17 per share for a total of $16500.0. Following the purchase, the insider now owns 1950.0 shares.

Zomedica Corp disclosed in a document filed with the SEC on Nov 17 ’23 that POWERS JOHNNY D (Director) bought a total of 100,000 shares of the company’s common stock. The trade occurred on Nov 17 ’23 and was made at $0.17 per share for $16600.0. Following the transaction, the insider now directly holds 1.85 million shares of the ZOM stock.

Still, SEC filings show that on Nov 17 ’23, HEATON LARRY C II (CEO) acquired 100,000 shares at an average price of $0.17 for $16600.0. The insider now directly holds 200,000 shares of Zomedica Corp (ZOM).

Related Posts